JD vs PTGX · P/E 7.6, rev $187.20B vs rev $269.8M
JD.com Inc Adr (JD) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
JD currently screens at market cap $45.56B and trailing P/E 7.6. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the JD and PTGX stock pages for the full models.
Not investment advice.